Table 4.
Treatment Changes due to Pregnancy, N=38
| Medication, N = Number receiving drug at time of pregnancy diagnosis |
Indefinitely suspended |
Suspended then resumed after pregnancy |
Continued throughout pregnancy |
Reinforcement post-partum |
|---|---|---|---|---|
| Injectables | ||||
| Streptomycin, N=2 | 1 | 0 | 1 | 0 |
| Kanamicin, N=13 | 5 | 8 | 0 | 0 |
| Amikacin, N=1 | 1 | 0 | 0 | 0 |
| Capreomycin, N=14 | 2 | 3 | 9 | 5 |
| Oral drugs | ||||
| Isoniazid, N=5 | 0 | 0 | 5 | 1 |
| Rifampin, N=3 | 0 | 0 | 3 | 0 |
| Ethambutol, N=9 | 1 | 0 | 8 | 1 |
| Pyrazinamide, N=15 | 0 | 0 | 15 | 0 |
| Fluoroquinolone, N=37 | 2 | 2 | 33 | 1 |
| Ethio/Prothio, N=28 | 7 | 7 | 14 | 0 |
| Cycloserine, N=32 | 4 | 2 | 26 | 0 |
| Para-aminosalicylic acid, N=28 |
5 | 2 | 21 | 0 |
| Amoxacillin-Clavulanate, N=17 |
3 | 0 | 14 | 2 |
| Clofazimine, N=4 | 1 | 3 | 0 | 0 |
| Rifabutin, N=1 | 0 | 0 | 1 | 0 |
| Clarithromycin, N=3 | 0 | 0 | 3 | 0 |